BM-MSC Analysis Cocktail Kit, anti-human

The BM-MSC Analysis Cocktail Kit, anti-human has been designed for the standardized analysis and quantification of mesenchymal stem cells (MSCs) from human bone marrow (BM) samples based on the expression of CD271 (LNGFR). The kit includes a ready-to-use analysis and control cocktail for fast and robust enumeration of MSCs. The additional MSC marker MSCA-1 allows the identification of MSCs with highly proliferative potential.

qualityAssuranceSatisfaction
guaranteed
more »

Related products for BM-MSC Analysis Cocktail Kit, anti-human

Product data and images for BM-MSC Analysis Cocktail Kit, anti-human
Figure 1

Correlation between numbers of CD271+MSCA-1+ cells determined by flow cytometry and numbers of CFU-F colonies. Bone marrow cells from 12 different samples were cultivated in 6-well plates (4×10⁵ cells per well) using StemMACS™ MSC Expansion Media Kit XF. The medium was replaced with fresh medium after 48 h and colonies were counted after 11 days. In addition, CD271+MSCA-1+ cells were quantified in the initial bone marrow samples by flow cytometry using the MSC Enumeration Kit.

Figure 2

Evaluation of experimental variation for the enumeration of CD271+MSCA-1+ MSCs. The numbers of CD271+MSCA-1+ cells in the MSC sample (stained with MSC Staining Cocktail) and control sample (stained with MSC Control Cocktail) were calculated for one milliliter of bone marrow aspirate (BMA) in six parallel experiments with a sample from a single donor.

Specifications for BM-MSC Analysis Cocktail Kit, anti-human
Overview

The BM-MSC Analysis Cocktail Kit, anti-human has been designed for the standardized analysis and quantification of mesenchymal stem cells (MSCs) from human bone marrow (BM) samples based on the expression of CD271 (LNGFR). The kit includes a ready-to-use analysis and control cocktail for fast and robust enumeration of MSCs. The additional MSC marker MSCA-1 allows the identification of MSCs with highly proliferative potential.

Detailed product information
Background information

BM-MSC Analysis Cocktail, anti-human containing:

  • CD45 Antibody, anti-human, FITC (clone: 5B1)
  • CD235a (Glycophorin A) Antibody, anti-human, VioBlue®, REAfinity™ (clone: REA175)
  • CD271 (LNGFR) Antibody, anti-human, PE (clone: ME20.4-1.H4)
  • MSCA-1 Antibody, anti-human, APC (clone: W8B2)

BM-MSC Control Cocktail, anti-human containing:

  • Isotype Control Antibody, mouse IgG1, APC (clone: IS5-21F5)
  • CD45 Antibody, anti-human, FITC (clone: 5B1)
  • CD235a (Glycophorin A) Antibody, anti-human, VioBlue®, REAfinity (clone: REA175)
  • CD271 (LNGFR) Antibody, anti-human, PE (clone: ME20.4-1.H4)

Additionally

  • Red Blood Cell Lysis Solution (10×)
  • FcR Blocking Reagent, human
  • 7-AAD Staining Solution

Instrument details

Flow cytometer equipped with a red (640 nm), a blue (488 nm), and a violet (405 nm) laser.

Applications

Analysis and standardized quantification of human MSCs from fresh bone marrow samples by flow cytometry.

Resources for BM-MSC Analysis Cocktail Kit, anti-human
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

To access a Safety Data Sheet for a hazardous product or component in English or Swedish language, follow the link below and enter the catalog number of the product.

Please note, that the Safety Data Sheet has a cover sheet only in English language.

Should you wish a Safety Data Sheet (SDS) in other languages than English or Swedish, please contact Technical Support.

Get Safety Data Sheet

Citations for BM-MSC Analysis Cocktail Kit, anti-human
Publications
  1. Cuthbert, R. et al. (2012) Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. Cytotherapy 14 (4): 431-440

You have previously chosen International as your location.
What do you want to do?